North East and North Cumbria (NENC) ICB are seeking NENC system-wide views on implementation of:
- Shared care protocol – Methylphenidate for patients within Paediatric Oncology – consultation closes at 5pm on Wednesday 14th October.
- NICE 30 day TA – mirdametinib for treating symptomatic and inoperable plexiform neurofibromas associated with neurofibromatosis type 1 in people 2 to 17 years – consultation closes at 5pm on Monday 19th October
Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to NTAG and used to inform implementation of the decisions in NENC.
All active consultations can be accessed at https://ntag.nhs.uk/consultations/.